CliffBio
small molecule

ALBUTEROL SULFATE

ALBUTEROL SULFATE

Loss of exclusivity—loss of exclusivity
CompanyPADAGIS US LLC

Drug detail

Brand nameALBUTEROL SULFATE
Active ingredientALBUTEROL SULFATE
StrengthEQ 0.09MG BASE/INH
Dosage formAEROSOL, METERED
RouteINHALATION
ModalitySmall molecule
FDA approvalFebruary 2020
Marketing statusRX

More from PADAGIS US LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

ALBUTEROL SULFATE patent cliff — loss of exclusivity — | CliffBio